Health Care & Life Sciences » Biotechnology | Theravance Biopharma Inc.

Theravance Biopharma Inc. | Ownership

Companies that own Theravance Biopharma Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Woodford Investment Management Ltd.
11,213,879
20.35%
315,000
2.24%
06/30/2018
The Baupost Group LLC
9,309,168
16.89%
0
2%
06/30/2018
Fidelity Management & Research Co.
7,929,504
14.39%
-71,507
0.02%
06/30/2018
The Vanguard Group, Inc.
3,459,786
6.28%
103,190
0%
06/30/2018
BlackRock Fund Advisors
3,387,901
6.15%
126,951
0.01%
06/30/2018
T. Rowe Price Associates, Inc.
1,740,780
3.16%
-604,415
0.01%
06/30/2018
Cormorant Asset Management LP
1,300,000
2.36%
0
2.66%
06/30/2018
Armistice Capital LLC
1,180,000
2.14%
1,180,000
2.6%
06/30/2018
SSgA Funds Management, Inc.
877,393
1.59%
15,942
0%
06/30/2018
Norges Bank Investment Management
774,797
1.41%
-91,927
0%
12/31/2017

About Theravance Biopharma

View Profile
Address
Ugland House
George Town GT KY1
Cayman Islands
Employees -
Website http://www.theravance.com
Updated 07/08/2019
Theravance Biopharma, Inc. operates as a biopharmaceutical company, which focuses on the discovery, development and commercialization of small molecule medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.